![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Author:
United States | Publication | March 2022
The United States Occupational Safety and Health Administration (OSHA) has reopened the rulemaking record and scheduled an informal public hearing concerning its development of a final standard to protect healthcare and healthcare support service workers from workplace COVID exposures.
Written comments must be submitted by April 22, 2022. Submit comments online, identified by Docket No. OSHA-2020-0004. Anyone wishing to testify at the hearing must submit a notice of intention to appear no later than 14 days after the publication of the Federal Register Notice. The online hearing begins on April 27, 2022.
In particular, OSHA is seeking comments on the following:
OSHA reminds employers to continue complying with their obligations under the General Duty Clause, Personal Protective Equipment and Respiratory Protection Standards to protect their employees from COVID hazards.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Over the past two years, Spain has significantly strengthened its foreign investment screening mechanism, and all acquisitions by foreign investors (as defined below) of a Spanish entity active in a strategic sector are subject to prior authorisation by the Ministry of Industry, Commerce and Tourism (“MoICT”).
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023